Use of l-carnitine and its alkanoyl derivatives for reducing...

Details Use of l-carnitine and its alkanoyl derivatives for reducing... Use of l-carnitine and its alkanoyl derivatives for reducing...

A - Human Necessities

61

K

A61K 38/13 (2006.01) A61K 31/205 (2006.01) A61K 31/22 (2006.01) A61K 31/221 (2006.01) A61K 31/435 (2006.01) A61K 31/445 (2006.01) A61K 47/18 (2006.01)

Patent

CA 2167456

The use of L-carnitine or of an alkanoyl L-carnitine or their pharmacologically acceptable salts is described for producing a medicament for inhibiting nephrotoxicity and vasculotoxicity resulting from the administration of an immunosuppressant drug such as cyclosporin-A, tacrolimus, rapamicine and deoxyspergualine.

Affiliated with

Also associated with

Rating

Use of l-carnitine and its alkanoyl derivatives for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of l-carnitine and its alkanoyl derivatives for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of l-carnitine and its alkanoyl derivatives for reducing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1654078